| 17.98 Delayed Data As of 4:01pm ET |  +0.70 / +4.05%Today’s Change | 14.59 Today|||52-Week Range 25.96 | +16.60% Year-to-Date |
| Previous close | 17.28 |
| Today’s open | 17.51 |
| Day’s range | 17.46 - 18.05 |
| Volume | 17,817,502 |
| Average volume (3 months) | 11,112,756 |
| Market cap | $22.5B |
| Earnings growth (last year) | -23,426.50% |
| Earnings growth (this year) | -27.03% |
| Earnings growth (next 5 years) | 0.00% |
| Revenue growth (last year) | +2.60% |
| P/E ratio | NM |
| Price/Sales | 0.85 |
| Price/Book | 1.63 |
| Today’s change | Today’s % change | |
|---|---|---|
| BGNEBeiGene Ltd | -2.46 | -1.83% |
| AKRXAkorn Inc | +0.11 | +2.54% |
| OASMOasmia Pharmaceutica... | +0.08 | +3.18% |
| Last reporting date | February 14, 2019 |
| EPS forecast (this quarter) | $0.55 |
| Annual revenue (last year) | $22.5B |
| Annual profit (last year) | -$16.4B |
| Net profit margin | -72.66% |
Sector Health Technology |
Industry Pharmaceuticals: Generic |
President, Chief Executive Officer & Director Kåre Schultz |
Executive Vice President- Global Operations Carlo de Notaristefani |
Corporate headquarters Petach Tikva, Hamerkaz |
